High amplification of FGFR1 gene is a delayed poor prognostic factor in early stage ESCC patients.

about

High amplification of FGFR1 gene is a delayed poor prognostic factor in early stage ESCC patients.

Item

http://www.wikidata.org/entity/Q47141559

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

High amplification of FGFR1 ge ...... in early stage ESCC patients.

@en

High amplification of FGFR1 ge ...... in early stage ESCC patients.

@nl

type

Item

label

High amplification of FGFR1 ge ...... in early stage ESCC patients.

@en

High amplification of FGFR1 ge ...... in early stage ESCC patients.

@nl

prefLabel

High amplification of FGFR1 ge ...... in early stage ESCC patients.

@en

High amplification of FGFR1 ge ...... in early stage ESCC patients.

@nl

P1476

High amplification of FGFR1 ge ...... in early stage ESCC patients.

@en

P2093

Akesu Sujie

http://www.w3.org/2001/XMLSchema#string

Chen Xu

http://www.w3.org/2001/XMLSchema#string

Dongxian Jiang

http://www.w3.org/2001/XMLSchema#string

Haixing Wang

http://www.w3.org/2001/XMLSchema#string

Haiying Zeng

http://www.w3.org/2001/XMLSchema#string

Jie Huang

http://www.w3.org/2001/XMLSchema#string

Qi Song

http://www.w3.org/2001/XMLSchema#string

Yalan Liu

http://www.w3.org/2001/XMLSchema#string

Yifan Xu

http://www.w3.org/2001/XMLSchema#string

Yingyong Hou

http://www.w3.org/2001/XMLSchema#string

P2860

Global cancer statistics

Cellular signaling by fibroblast growth factor receptors

Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial.

Frequent and focal FGFR1 amplification associates with therapeutically tractable FGFR1 dependency in squamous cell lung cancer.

Fibroblast growth factor receptor 1 gene amplification is associated with poor survival and cigarette smoking dosage in patients with resected squamous cell lung cancer.

Protein tyrosine kinase structure and function

Genomic and molecular characterization of esophageal squamous cell carcinoma

Genomic and transcriptional aberrations linked to breast cancer pathophysiologies

Prognostic role of FGFR1 amplification in early-stage non-small cell lung cancer.

Identification of genomic alterations in oesophageal squamous cell cancer.

P304

74539-74553

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.20215

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-08-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29088806

http://www.w3.org/2001/XMLSchema#string

P932

5650361

http://www.w3.org/2001/XMLSchema#string